West Pharmaceutical Services, Inc. (WST) Balance Sheet
As of 2026-06-30 (10-Q), West Pharmaceutical Services, Inc. (WST) reported total assets of $4.1B, total liabilities of $1.1B and shareholders' equity of $3.0B, according to EquiReason's reading of its SEC filings. Cash and equivalents: $435.8M. Long-term debt: $202.9M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
WSTWest Pharmaceutical Services, Inc.Follow WST — free
—
Price chart with a free account
- Market cap
- 27.6B
- P/E TTM
- 50.2
- Dividend yield
- 0.2%
- 52-week
- —
- Next earnings
- 29 Oct, in 5 days
| Line | FY2010 Dec 10 | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 0.11 | 0.09 | 0.16 | 0.23 | 0.26 | 0.27 | 0.20 | 0.24 | 0.34 | 0.44 | 0.62 | 0.76 | 0.89 | 0.85 | 0.48 | 0.79 | 0.44 | |
| Short-term investments | 0.00 | 0.03 | 0.01 | 0.01 | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Receivables | 0.13 | 0.15 | 0.18 | 0.19 | 0.18 | 0.18 | 0.20 | 0.25 | 0.29 | 0.32 | 0.39 | 0.49 | 0.51 | 0.51 | 0.55 | 0.57 | 0.71 | |
| Inventory | 0.15 | 0.15 | 0.16 | 0.18 | 0.18 | 0.18 | 0.20 | 0.22 | 0.21 | 0.24 | 0.32 | 0.38 | 0.41 | 0.43 | 0.38 | 0.44 | 0.45 | |
| Current assets | 0.44 | 0.47 | 0.56 | 0.65 | 0.66 | 0.67 | 0.64 | 0.74 | 0.89 | 1.06 | 1.37 | 1.74 | 1.92 | 1.94 | 1.54 | 1.98 | 1.81 | |
| Total assets | 1.29 | 1.40 | 1.56 | 1.67 | 1.67 | 1.70 | 1.72 | 1.86 | 1.98 | 2.34 | 2.79 | 3.31 | 3.62 | 3.83 | 3.64 | 4.27 | 4.08 | |
| Current liabilities | 0.17 | 0.24 | 0.26 | 0.24 | 0.25 | 0.31 | 0.24 | 0.28 | 0.28 | 0.34 | 0.50 | 0.59 | 0.52 | 0.67 | 0.55 | 0.65 | 0.64 | |
| Long-term debt | 0.36 | 0.30 | 0.38 | 0.37 | 0.31 | 0.23 | 0.23 | 0.20 | 0.20 | 0.26 | 0.25 | 0.21 | 0.21 | 0.07 | 0.20 | 0.20 | 0.20 | |
| Short-term debt | 0.00 | 0.05 | 0.03 | 0.00 | 0.03 | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 | 0.00 | 0.13 | 0.00 | 0.00 | 0.00 | |
| Total liabilities | 0.67 | 0.74 | 0.84 | 0.77 | 0.71 | 0.67 | 0.60 | 0.58 | 0.58 | 0.77 | 0.94 | 0.98 | 0.93 | 0.95 | 0.96 | 1.09 | 1.09 | |
| Shareholders' equity | 0.63 | 0.65 | 0.73 | 0.91 | 0.96 | 1.02 | 1.12 | 1.28 | 1.40 | 1.57 | 1.85 | 2.34 | 2.68 | 2.88 | 2.68 | 3.18 | 2.99 |
USD billions · SEC XBRL
West Pharmaceutical Services, Inc. — questions
- How much cash does West Pharmaceutical Services, Inc. have?
- $435.8M in cash and cash equivalents as of 2026-06-30.
- How much debt does West Pharmaceutical Services, Inc. have?
- $202.9M of long-term debt and $0 due within a year as of 2026-06-30.
- What are West Pharmaceutical Services, Inc.'s total assets?
- $4.1B as of 2026-06-30.
- What is West Pharmaceutical Services, Inc.'s shareholders' equity?
- $3.0B as of 2026-06-30.
Every figure on this page comes from West Pharmaceutical Services, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.